Clearstead Advisors’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29K | Buy |
23,550
+1,550
| +7% | +$1.91K | ﹤0.01% | 1470 |
|
|
2025
Q1 | $24.2K | Hold |
22,000
| – | – | ﹤0.01% | 1359 |
|
|
2024
Q4 | $19.9K | Hold |
22,000
| – | – | ﹤0.01% | 1386 |
|
|
2024
Q3 | $21.7K | Hold |
22,000
| – | – | ﹤0.01% | 1391 |
|
|
2024
Q2 | $19.8K | Hold |
22,000
| – | – | ﹤0.01% | 1380 |
|
|
2024
Q1 | $15.8K | Hold |
22,000
| – | – | ﹤0.01% | 978 |
|
|
2023
Q4 | $20.1K | Sell |
22,000
-22,000
| -50% | -$20.1K | ﹤0.01% | 940 |
|
|
2023
Q3 | $36.6K | Buy |
44,000
+22,000
| +100% | +$18.3K | ﹤0.01% | 930 |
|
|
2023
Q2 | $26.4K | Hold |
22,000
| – | – | ﹤0.01% | 853 |
|
|
2023
Q1 | $27.7K | Buy |
22,000
+18,500
| +529% | +$23.3K | ﹤0.01% | 790 |
|
|
2022
Q4 | $7.6K | Hold |
3,500
| – | – | ﹤0.01% | 939 |
|
|
2022
Q3 | $42K | Hold |
3,500
| – | – | ﹤0.01% | 639 |
|
|
2022
Q2 | $29K | Hold |
3,500
| – | – | ﹤0.01% | 725 |
|
|
2022
Q1 | $30K | Hold |
3,500
| – | – | ﹤0.01% | 776 |
|
|
2021
Q4 | $40K | Hold |
3,500
| – | – | ﹤0.01% | 690 |
|
|
2021
Q3 | $44K | Hold |
3,500
| – | – | ﹤0.01% | 627 |
|
|
2021
Q2 | $28K | Hold |
3,500
| – | – | ﹤0.01% | 645 |
|
|
2021
Q1 | $32K | Hold |
3,500
| – | – | ﹤0.01% | 599 |
|
|
2020
Q4 | $34K | Buy |
3,500
+2,500
| +250% | +$24.3K | ﹤0.01% | 562 |
|
|
2020
Q3 | $12K | Hold |
1,000
| – | – | ﹤0.01% | 642 |
|
|
2020
Q2 | $13K | Hold |
1,000
| – | – | ﹤0.01% | 572 |
|
|
2020
Q1 | $10K | Buy |
+1,000
| New | +$10K | ﹤0.01% | 577 |
|